Literature DB >> 22179019

Regulation of mouse Cyp24a1 expression via promoter-proximal and downstream-distal enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3) action.

J Wesley Pike1, Mark B Meyer.   

Abstract

CYP24A1 functions in vitamin D target tissues to degrade 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)). Thus, the concentration of this enzyme and the regulation of its expression is a primary determinant of the overall biological activity of 1,25(OH)(2)D(3) within cells. The principle regulator of CYP24A1 expression is 1,25(OH)(2)D(3) itself, which functions through the vitamin D receptor to upregulate the transcriptional activity of the Cyp24a1 gene. In this report, we explore the mechanism of this regulation using recently developed ChIP-chip and ChIP-seq techniques that permit an unbiased search for enhancer elements that participate in this transcriptional control. Our studies both confirm a regulatory region defined earlier and located proximal to the transcriptional start site (TSS) of mouse Cyp24a1 (-160 and -265nt) and identify a novel intergenic region located downstream of the transcription unit that contains two enhancers (+35 and +37kb) that facilitate 1,25(OH)(2)D(3)-dependent upregulation of Cyp24a1 expression. Interestingly, while C/EBPβ also binds under basal conditions to a site located immediately upstream of the Cyp24a1 promoter (-345nt), occupancy by this factor is strikingly increased following 1,25(OH)(2)D(3) treatment. The locations and activities of these regulatory regions that mediate 1,25(OH)(2)D(3) actions were confirmed in mice in vivo. We conclude that the mechanism through which 1,25(OH)(2)D(3) induces the CYP24A1 enzyme, thereby autoregulating its own destruction, involves both promoter-proximal as well as downstream-distal enhancers. These findings highlight new concepts regarding the molecular mechanism of action of 1,25(OH)(2)D(3) and other hormonal regulators.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22179019      PMCID: PMC3314719          DOI: 10.1016/j.abb.2011.12.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  63 in total

1.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.

Authors:  D G Albertson; B Ylstra; R Segraves; C Collins; S H Dairkee; D Kowbel; W L Kuo; J W Gray; D Pinkel
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction.

Authors:  P P Dwivedi; J L Omdahl; I Kola; D A Hume; B K May
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets.

Authors:  O Dardenne; J Prud'homme; A Arabian; F H Glorieux; R St-Arnaud
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

4.  Emerging regulatory paradigms for control of gene expression by 1,25-dihydroxyvitamin D3.

Authors:  J Wesley Pike; Mark B Meyer; Melissa L Martowicz; Kathleen A Bishop; Seong Min Lee; Robert D Nerenz; Paul D Goetsch
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-07       Impact factor: 4.292

5.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

6.  Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5.

Authors:  Prem P Dwivedi; Charles S T Hii; Antonio Ferrante; Joseph Tan; Channing J Der; John L Omdahl; Howard A Morris; Brian K May
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

7.  Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.

Authors:  K Mimori; Y Tanaka; K Yoshinaga; T Masuda; K Yamashita; M Okamoto; H Inoue; M Mori
Journal:  Ann Oncol       Date:  2004-02       Impact factor: 32.976

8.  Direct repeat 3-type element lacking the ability to bind to the vitamin D receptor enhances the function of a vitamin D-responsive element.

Authors:  K Ozono; M Yamagata; Y Ohyama; S Nakajima
Journal:  J Steroid Biochem Mol Biol       Date:  1998-09       Impact factor: 4.292

Review 9.  Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone.

Authors:  Claudia Zierold; Jamie A Mings; Hector F DeLuca
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

Review 10.  Enzymes involved in the activation and inactivation of vitamin D.

Authors:  David E Prosser; Glenville Jones
Journal:  Trends Biochem Sci       Date:  2004-12       Impact factor: 13.807

View more
  20 in total

1.  1,25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components.

Authors:  Seong Min Lee; Erin M Riley; Mark B Meyer; Nancy A Benkusky; Lori A Plum; Hector F DeLuca; J Wesley Pike
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

Review 2.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

3.  A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation.

Authors:  Mark B Meyer; Nancy A Benkusky; Martin Kaufmann; Seong Min Lee; Melda Onal; Glenville Jones; J Wesley Pike
Journal:  J Biol Chem       Date:  2017-08-14       Impact factor: 5.157

Review 4.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

5.  24,25-Dihydroxyvitamin d3 and vitamin D status of community-dwelling black and white Americans.

Authors:  Anders H Berg; Camille E Powe; Michele K Evans; Julia Wenger; Guillermo Ortiz; Alan B Zonderman; Pirianthini Suntharalingam; Kathryn Lucchesi; Neil R Powe; S Ananth Karumanchi; Ravi I Thadhani
Journal:  Clin Chem       Date:  2015-04-28       Impact factor: 8.327

6.  Murine CD8+ T cells but not macrophages express the vitamin D 1α-hydroxylase.

Authors:  Jot Hui Ooi; Kaitlin L McDaniel; Veronika Weaver; Margherita T Cantorna
Journal:  J Nutr Biochem       Date:  2013-10-10       Impact factor: 6.048

Review 7.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3.

Authors:  Seong Min Lee; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-29       Impact factor: 4.292

9.  Vitamin D status and metabolism in an ovine pregnancy model: effect of long-term, high-altitude hypoxia.

Authors:  Ravi Goyal; Tara L Billings; Trina Mansour; Courtney Martin; David J Baylink; Lawrence D Longo; William J Pearce; Eugenia Mata-Greenwood
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-03       Impact factor: 4.310

10.  1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6.

Authors:  Rimpi K Saini; Ichiro Kaneko; Peter W Jurutka; Ryan Forster; Antony Hsieh; Jui-Cheng Hsieh; Mark R Haussler; G Kerr Whitfield
Journal:  Calcif Tissue Int       Date:  2012-12-22       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.